Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Translation and cultural adaptation of the GENDER-Q with pilot implementation among patients undergoing masculinizing chest surgery.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026

Same author

[Generational shift in clinical urological care: status quo in German urology].

Urologie (Heidelberg, Germany)·2026

Same author

Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non-Obstructive Azoospermia?

Andrology·2026

Same author

Clinical document metadata extraction: A scoping review.

Journal of biomedical informatics·2026

Same author

Automating the segmentation, date extraction, and classification of multi-report PDFs in outside medical records using optical character recognition and generative artificial intelligence.

JAMIA open·2026

Same author

Digital Therapy for Male LUTS: Results After Mid- and Longterm Follow-Up.

Journal of clinical medicine·2026

Search research articles

Related Experiment Video

Updated: Jun 24, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

App-based Therapy of Erectile Dysfunction Using a Digital Health Application (EDDIG Study): A Randomized,

Sabine Kliesch¹, Jann-Frederik Cremers¹, Claudia Krallmann¹

¹Centre of Reproductive Medicine and Andrology, Department of Clinical and Surgical Andrology, University Clinic Münster, Münster, Germany.

European Urology Focus

|June 9, 2024

Summary

This summary is machine-generated.

An app-based therapy significantly improved erectile function (ED) and quality of life in men. This digital health solution offers a promising new approach for ED treatment.

Keywords:

App-based therapeutics Digital therapeutics Ehealth Erectile dysfunction Impotence Sexual health

More Related Videos

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

Published on: February 3, 2022

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Related Experiment Videos

Last Updated: Jun 24, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

An Application for Pairing with Wearable Devices to Monitor Personal Health Status

Published on: February 3, 2022

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Area of Science:

Digital Health
Urology
Men's Health

Background:

International guidelines recommend a comprehensive approach for erectile dysfunction (ED) treatment.
Structured programs integrating physical, psychological, and educational elements are often lacking.
An app-based therapeutic was developed to provide a systematic approach to ED management.

Purpose of the Study:

To assess the effectiveness of a novel app-based therapeutic intervention for erectile dysfunction.
To evaluate improvements in erectile function, quality of life, and patient activation.
To determine the clinical utility of digital therapeutics in ED care.

Main Methods:

A randomized, single-blind controlled trial involving 241 patients with ED (IIEF-5 <22).
Patients were assigned to a 12-week app-based therapy (treatment group) or a control group (waiting list).
Coprimary endpoints included changes in erectile function (IIEF-5), quality of life (QOL-Med-15), and patient activation (PAM-13) from baseline to 12 weeks.

Main Results:

Significant improvements were observed in the treatment group compared to the control group for all coprimary endpoints.
Erectile function (IIEF-5) improved by 4.5 points vs. 0.2 points (p < 0.0001).
Quality of life (QOL-Med) improved by 20.5 points vs. 0.0 points (p < 0.0001), and patient activation (PAM-13) by 11.2 points vs. 0.6 points (p < 0.0001).

Conclusions:

App-based therapy demonstrated significant and clinically meaningful improvements in patients with ED.
The intervention also led to significant enhancements in quality of life and patient activation.
This digital therapeutic holds potential to transform clinical practice for ED treatment.